Devic's neuromyelitis optica: A critical review

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 1, 2008, Pages 120-138

  Lana Peixoto, Marco Aurélio ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NONE   (Brazil)

Author keywords

Aquaporin 4; Devic's neuromyelitis optica; NMO IgG antibody; Opticospinal multiple sclerosis; Recurring optic neuritis; Transverse myelitis

Indexed keywords

AQUAPORIN 4; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GADOLINIUM; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ASTROCYTE; BLOOD VESSEL WALL; CELL INFILTRATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DEMYELINATING DISEASE; DISEASE COURSE; DISEASE MARKER; DRUG MEGADOSE; EOSINOPHIL; GENETIC ANALYSIS; GRANULOCYTE; HUMAN; HYALINE DEGENERATION; MULTIPLE CYCLE TREATMENT; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; PATHOGENESIS; PLASMAPHERESIS; RELAPSE; REVIEW; SENSITIVITY AND SPECIFICITY; SPINAL CORD; SPINAL CORD LESION;

EID: 42049118072     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000100034     Document Type: Review

References (188)

1. Okinaka S, Tsubaki T, Kuroiwa Y, Toyokura Y, Imamura Y, Yoshikawa M. Multiple sclerosis and allied diseases in Japan. Neurology 1958;8:756-763.
2. Okinaka S, McAlpine D, Miyagawa K, et al. Multiple sclerosis in northern and southern Japan. World Neurol 1960;1:22-42.
3. Shibasaki H, Kuroda Y, Kuoroiwa Y. Clinical studies of multiple sclerosis in Japan: classical multiple sclerosis and Devic's disease. J Neurol Sci 1974;23;215-222.
4. Kuroiwa Y, Kurland LT. Multiple sclerosis, East and West. Fukuoka. Kyshu University Press. Basel-Munich: Karger, 1982.
5. Ikuta F. Problems in thae pathoanatomy of multiple sclerosis: realities of MS problems on the US and Japanese cases. Kuroiwa Y (Ed). Multiple sclerosis in Asia. Tokyo: University of Tokyo Press 1976:143-158.
6. Ikuta F, Koga M, Takeda S, et al. Comparison of MS pathology between 70 American and 75 Japanese autopsy cases. Kuroiwa Y, Kurland LT (Eds). Multiple sclerosis, East and West. Fukuoka: Kyushu University Press. Basel-Munich: Karger, 1982:297-306.
7. Kuroiwa Y. Neuromyelitis optica (Devic's disease, Devic's syndrome). Koetsier JC (Ed). Demyelinating diseases. Handbook of clinical neurology. Amsterdam: Elsevier Science Publishers B.V., 1985:397-408.
8. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-1114.
9. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002;125:1450-1461.
10. Lennon VA, Wingerchuk DM, Kryser TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-2112.
11. Lennon VA, Kryser TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-477.
12. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390-396.
13. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006;77:1073-1075.
14. Weinshenker BG. Neuromyelitis optica: what it is and what it might be. Lancet 2003;361:889-890.
15. Allbutt TC. On the ophthalmoscopic signs of spinal disease. Lancet 1870;1:76-78.
16. Erb W. Über das Zusammenkommen von Neuritis optica und Myelitis subacute. Arch Psychiatr Nervenkr 1879-1880;1:146-157.
17. Seguin EC. On the coincidence of optic neuritis and subacute transverse myelitis. J Nerv Ment Dis 1880;7:177-188.
18. Steffan P. Beitrag zur Lehre des Zusammenhanges der Erkrankungen der Sehnerven mit denen des Rückenmarkes. Opthalmol Gesellschaft (Heidelberg) 1879;12:90.
19. Noyes HD. Acute myelitis mit doppelseitiger Neuritis optica. Arch F Augenheilk 1881:331.
20. Chisolm JJ. An obscure case in nerve pathology accompanying optic neuritis. Arch Ophthalmol 1882;11:239.
21. Dreschfeld J. Acute myelitis associated with optic neuritis. Lancet 1882;1:8, 52-53.
22. Devic E. Myélite subaiguë compliquée de névrite optique. Bull Med (Paris) 1894;8:1033-1034.
23. Gault F. De la neuromyélite optique aiguë. Thèse. Lyon, France: 1894.
24. Acchiote P. Sur un cas de neuromyélite subaiguë ou maladie de Devic. Rev Neurol (Paris)1907;20:775-777.
25. Goulden C. Optic neuritis and myelitis. Opthalmol Rev 1914;34:193-209.
26. Beck GM. A case of diffuse myelitis associated with optic neuritis. Brain 1927;50:687-703.
27. Hassin GB. Neuroptica myelitis versus multiple sclerosis: a pathologic study. Arch Neurol Psychiatry 1937;37:1083-1099.
28. Lowenberg K, DeJong RN, Foster DB. Neuromyelitis optica: its relations to progressive necrosis of the spinal cord and acute multiple sclerosis. Trans Am Neurol Assoc 1947;67:50-66.
29. Stansbury FC. Neuromyelitis optica (Devic's disease): presentation of five cases with pathological study and review of the literature. Arch Ohthalmol 1949;42:292-335,465-501.
30. Scott GI. Neuromyelitis optica. Am J Ophthalmol 1952;35:755-764.
31. Walsh FB. Neuromyelitis optica: anatomical-pathological study of one case: clinical studies of three additional cases. Bull Johns Hopkins Hosp 1935;56:183-210.
32. Peters G. Neuromyelitis optica. Lubarsche O, Henke F, Rossle R.(Eds). Handbuch der speziellen pathologischen Anatomie und Histologie, Bd. XIII. IIA: Erkrankugen des zentralen Nerven Systems. Berlin: Springer, 1958:630-644.
33. Marques A. Da neuromielite ótica: contribuição clínica e etiológica. Hospital 1943;24;49-63.
34. Shibasaki H, McDonald I, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between Japanese and British patients. J Neurol Sci 1981;49:253-271.
35. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993;34:162-168.
36. O'Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996;60:382-387.
37. Wingerchuk DM, Lennon VA, Pittocj SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489.
38. Denker BM, Smith BL, Kuhajda FP, Agre P. J Biol Chem 1988;263:15634- 15642.
39. Kira JI, Kanai T, Nishimura Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996;40:569-574.
40. Kira JI. Multiple sclerosis in the Japanese population. Lancet Neurol 2003;2:117-127.
41. Kuroiwa Y, Hung TP, Landsborough D, Park CS, Singhal BS. Multiple sclerosis in Asia. Neurology 1977;1977:188-192.
42. Osuntokun BO. The pattern of neurological illness in tropical Africa: experience at Ibadan, Nigeria. J Neurol Sci 1971;12:417-442.
43. Modi G, Mochan A, Modi M, Saffer D. Demyelinating disorder of the central nervous system occurring in Black South Africans. J Neurol Neurosurg Psychiatry 2001;70:500-505.
44. Hung TP, Landsborough D, His MS. Multiple sclerosis amongst Chinese in Taiwan. J Neurol Sci 1976;27:759-784.
45. Yu YI, Woo E, Hawkins BR, Cho HC, Hung CY. Multiple sclerosis amongst Chinese in Hong Kong. Brain 1989;112:1445-1467.
46. Lau KK, Wong LKS, Li LSW, Chan YW, Li HI, Wong V. Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey. Hong Kong Med J 2002;8:77-80.
47. Hung TP, Landsborough D, His MS. Multiple sclerosis amongst Chinese in Taiwan. J Neurol Sci 1976;27:759-784.
48. Kurtzke JF, Park CS, Oh SJ. Multiple sclerosis in Korea: clinical features and prevalence. J Neurol Sci 1968;6:463-481.
49. Singhal BS. Clinical profile and HLA studies in Indian multiple sclerosis patients from the Bombay region. Kuroiwa Y, Kurland LT (Ed). Multiple sclerosis, East and West. Fukuoka: Kyushu University Press. Basel-Munich: Karger, 1982:123-134.
50. Tan CT. Multiple sclerosis in Malaysia. Arch Neurol 1988;45:624-627.
51. Vejajiva A. Some clinical aspects of multiple sclerosis in Thai patients. Kuroiwa Y, Kurland LT (Eds). Multiple Sclerosis, East and West. Fukuoka: Kyushu University Press. Basel-Munich: Karger, 1982:117-121.
52. Kuroiwa Y, Shibasaki H, Ikeda M. Prevalence of multiple sclerosis and its north-to-south gradient in Japan. Neuroepidemiology 1983;2:62-69.
53. Kuroiwa Y, Igata A, Itahara K, et al. Nationwide survey of multiple sclerosis in Japan: clinical analysis of 1084 cases. Neurology 1975;25:845-851.
54. Kuroiwa Y, Shibasaki H, Tabira T, Itoyama Y. Clinical picture of multiple sclerosis in Asia. Kuroiwa Y, Kurland LT (Eds). Multiple sclerosis, East and West: Fukuoka, Kyushu University Press. Basel-Munich: Karger, 1982:31-42.
55. Bharucha EP, Umarji RM. Disseminated sclerosis in India. Int J Neurol 1961;2:182-188.
56. Nair KR, Sahasranam. Multiple sclerosis in Malabar. J Ass Physicians India 1978;26:899-903.
57. Chopra JS, Radhakrishnan, Sawhney BB, Pal SR, Banerjee AL. Multiple sclerosis in North-West India. Acta Neurol Scand 1980;62:312-321.
58. Ghouri-Devi M, Nagaraja D. Multiple sclerosis in South India. . Kuroiwa Y, Kurland LT (Eds). Multiple sclerosis, East and West. Fukuoka: Kyushu University Press. Basel-Munich: Karger, 1982:57-70.
59. Kim SW, Kim SK. Multiple sclerosis in Busan, Korea. Kuroiwa Y, Kurland LT (Ed). Multiple sclerosis, East and West. Fukuoka: Kyushu University Press. Basel-Munich: Karger, 1982:57-70.
60. Navarro JC, Sobrevega EE, Gomez GL, Cuanang JR. Multiple sclerosis in the Philippines. Kuroiwa Y, Kurland LT (Eds). Multiple sclerosis, East and West. Fukuoka: Kyushu University Press. Basel-Munich: Karger, 1982: 97-104.
61. Renales RD, Zaraspe-Yoo E, Perez MC, Zamuco JT, Martin DR. Multiple sclerosis among Filipinos: clinical review and report of two cases Kuroiwa Y, Kurland LT (Eds ). Multiple sclerosis, East and West. Fukuoka: Kyushu University Press. Basel-Munich: Karger, 1982:105-116.
62. Mirsattari SM, Johston JB, McKenna R, Del Bigio MR, Orr P, Ross RT, Power C. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology 2001;56:317-323.
63. Araki S, Uchinoi M, , Yoshida O. Epidemiological study of multiple sclerosis, myasthenia gravis and polymyositis in the city of Kumamoto, Japan. Rinshoshinkeigaku 1983;23:838-841.
64. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007;130:1206-1223.
65. Housen H, Kikuchi S, Tashiro K, Matsumoto H. Epidemiological study of multiple sclerosis in Tokachi, Hokkaido. The 43erd Congress of Japanese Society of Neurology 2002: Abstr II-F01.
66. Al-Din ASN, Khogali M, Poser CM, et al. Epidemiology of multiple sclerosis in Arabs in Kuwaiti: a comparative study between Kuwatis and Palesstinians. J Neurol Sci 1990;100:137-141.
67. Yaqub BA, Daif AK. Multiple sclerosis in Saudi Arabia. Neurology 1988;38:621-623.
68. Cabre P, Heinzlef O, Merle H, et al. MS and neuromyelitis optica in Martinique (French West Indies).Neurology 2001;56:507-514.
69. Merle H, Olindo S, Bonnan M, Donnio A, Richer R, Smadja D, Cabre P. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology 2007;114:810-815.
70. Patrucco LB, Cristiano E, Videla CG, Bauso Toselli PL. Devic's neromyelitis optica (NMO) and multiple sclerosis (MS): clinical and epidemiological findings in a MS Center in Argentina. Mult Scler 2002;8(Suppl 1):S37.
71. Lana-Peixoto MA, Lana-Peixoto MI. Is multiple sclerosis in Brazil and Asia alike? Arq Neuropsiquiatr 1992;50:419-425.
72. Papais-Alvarenga, Miranda-Santos CM, Puccioni-Sohler M, et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 2002;73:429-435.
73. Jeffery AR, Buncic JR. Pediatric Devic's neuromyelitis optica. J Pediatr Ophthalmol Strabismus 1996;33: 223-229.
74. Yuksel D, Senbil N, Yilmaz D, Yavuz Gurer YK. Devic's neuromyelitis optica: an infant case. J Child Neurol 2007;22;1143-1146 .
75. Filley CM, Stemberg PE, Noremberg MD. Neuromyelitis optica in the elderly. Arch Neurol 1984;41:670-672.
76. Ghezzi M, Giansanti M, Malentacchi GM, Barontini F. Neuromyelitis optca in the old age: a clinicopathological contribution. Ital J Neurol Sci 1987;8:613-616.
77. Barbieri F, Busacino GA. Neuromyelitis optica in the elderly. Acta Neurol (Napoli)1989;11:247-251.
78. Staugaitis SM, Roberts JK, Sacco RL, Miller JR, Dwork AJ. Devic type multiple sclerosis in an 81-year old woman. J Neurol Neurosurg Psychiatry 1988;64:417-418.
79. Wingerchuck DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003;60:848-853.
80. Banwell B, Tenebaum S, Lennon VA, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2007. Available at www.ncbi.nlm.nih.gov/pubmed/
81. Staugaitis SM, Roberts JK, Sacco RL, Miller JR, Dwork AJ. Devic type multiple sclerosis in an 81-year old woman. J Neurol Neurosurg Psychiatry 1998;64:417-418.
82. Yamasaki K, Horiuchi I, Minohara M, et al. HLA-DPB1*0501- associatedopticospinal multiple sclerosis. Clinical, neuroimaging and immunogenetic studies. Brain 1999;122:1689-1696.
83. Fukazawa T, Kikuchi S, Miyagishi Y, Yabe I, Hamada T, Sasaki H. HLA-DPB1* 0501 is not uniquely associated with opticospinal multiple sclerosis in Japanese patients: important role of DPB1*0301. Mult Scler 2006;12:19-23.
84. McAlpine D. Familial neuromyelitis optica: its occurrence in identical twins. Brain 1938;1:430-438.
85. Ch'len LT, Medeiros Mo, Belluomini JJ, Lemmi H, Whitaker JN. Neuromyelitis optica (Devic's syndrome) in two sisters. Clin Electoencephalogr 1982;13:36-39.
86. Yamanaka K, Kuroda H, Fujihara K, et al. Familial neuromyelitis optica (Devic's syndrome ) with late onset in Japan. Neurology 2000;25:318-320.
87. Keegan M, Weinshenker B. Familial Devic's disease. Can J Neurol Sci 2000;27(Suppl):S57-S58.
88. Bradley T, Mikol DD. Neuromyelitis optica in a mother and daughter. Arch Neurol 2007;64:1189-1192.
89. Kister I, Gulati S, Boz Z, et al. Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 2006;63:851-856. Erratum in: Arch Neurol 2006;63:1342.
90. Cloys DE, Netsky MG. Neuromyelitis optica. Vinken PJ, Bruyn GW (Eds). Handbook of clinical neurology. Vol 9. Amsterdam:North Holland, 1970:426-436.
91. th Ed. London:Arnold, 1997:813-896.
92. Lucchinetti CW, Brúck J, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenicity of demyelination. Ann Neurol 2000;47:707-717.
93. Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassman H. Multiple sclerosis: in situ evidence for antibody-and complement-mediated demyelination. Ann Neurol 1988;43:465-471.
94. Harada T, Ohashi T, Harada C, et al. A case of bilateral optic neuropathy and recurrent transverse myelopathy associated with perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA). J Neuroophthalmol 1997;17:254-256.
95. Karussis D, Leker RR, Ashkenazi A, Abramsky O. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 1998;44:629-634.
96. Pedersen C, Bonen H, Boesen F. Transverse myelitis in mixed connective tissue disease. Clin Rheumatol. 1987;6:290-292.
97. Mok CC, Lau CS. Transverse myelopathy complicating mixed connective tissue disease. Clin Neurol Neurosurg 1995;97:259-260.
98. Arabashi B, Pollock AN, Sherry DD, Albert DA, Kreiger PA, Pessler F. Devic disease in a child with primary Sjögren syndrome. J Child Neurol 2006;21:285-286.
99. de Seze J, Stojkovic T, Hachulla E, et al. Myelopathy-Sjögren syndrome association: analysis of clinical and radiological findings in clinical course. Rev Neurol (Paris) 2001;157:669-678.
100. April RS, Vansonnenberg E. A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: clinicopathologic report and review of the literature. Neurology 1976:26:1066-1070.
101. Bonnet F, Mercié P, Morlat P, et al. Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus. Lupus 1999;8:244-247.
102. Inslicht DV, Stein AB, Pormerantz F, Ragnarsson KT. Three women with lupus transverse myelitis:case reports and differential diagnosis. Arch Phys Med Rehabil 1998;79:456-459.
103. Margaux J, Hayem G, Meyer O, Khan MF. Systemic lupus erythematosus with optical neuromyelitis (Devic's syndrome): a case with 35-year follow-up. Rev Rheum 1999;66:102-105.
104. Lehmann HC, Hartung HP, Hetzel GR, Stuve O, Kieseier BC. Plasma exchange in neuroimmunological disorders: Part 1. rationale and treatment of inflammatory central nervous system disorders. Arch Neurol 2006;63:930-935.
105. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinschenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002;58:142-146.
106. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998;51:1219-1220.
107. Bergamaschi R. Immune agents for the treatment of Devic's neuromyelitis optica. Neurol Sci 2007;28:238-240.
108. Nakamura M, Endo M, Murakami K, Konno H, Fujihara K, Itoyama Y. An autopsied case of neuromyelitis optica with large cavitary cerebral lesion. Mult Scler 2005;11:735-738.
109. Hengstman GjD, Wesseling P, Frenken CWGM, Jongen PJH. Neuromyelitis optica with clinical and pathological involvement of the brain. Mult Scler 2007;13:679-682.
110. Takahashi T, Fujihara K, Nakashima I, et al.Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007;130:1235-1243.
111. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007;130:1206-1223.
112. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci 2003;4:991-1001.
113. Tait MJ, Saadoun S, Bell BA, Papadopoulos MC. Water movements in the brain: role of aquaporins. Trends Neurosci 2007. Available at www.ncbi.nlm.nih.gov/pubmed
114. Amiry-Moghaddam M, frydenlund DS, Ottersen OP. Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport. Neuroscience 2004;129:999-1010.
115. Benarroch E. Aquaporin-4, homeostasis, and neurologic disease. Neurology 2007;69: 2226-2228.
116. Naggelhus EA, Horio Y, Inanobe A, et al. Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Müller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains. Glia 1999;26:47-54.
117. Zeng XN, Sun XL, Gao L, Fan Y, Ding JH, Hu G. Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes. Mol Cell Neurosci 2007;34:34-39.
118. Benarroch EE. Aquaporin-4, homeostasis, and neurologic disease. Neurology 2007;69:2266-2268.
119. Griesdale DE, Honey CR. Aquaporins and brain edema. Surg Neurol 2004;61:34-39.
120. Manley GT, Fujimara M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000;6:159-163.
121. Misu T. Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005;65:1479-1482.
122. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006;77:1073-1075.
123. Pittock SJ, Wewinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006;63:964-968.
124. Misu T, Fujihara K, Nakamura M, et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.Tohoku J Exp Med. 2006;209:269-275.
125. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007;130:1194-1205.
126. Sinclair C, Kirk J, Herron B, Fitzgerald U, McQuaid S. Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathl 2007;113:187-194.
127. Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain. 2007;130:1224-1234.
128. Wingerchuk DM. Neuromyelitis optica: new findings on pathogenesis. Int rev Neurobiol 2007;79:665-688.
129. Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Opin Neurol 2007;20:255-260.
130. Tait MJ, Saadoun S, Bell BA, Papadopoulos MC. Water movements in the brain: role of aquaporins. Trends Neurosci 2007. Available at www.ncbi.nlm.nih.gov/pubmed/
131. Osoegawa M, Niino M, Tanaka M, et al. Comparison of clinical courses of opticospinal and conventional forms of multiple sclerosis in Japan. Intern Med 2005;44:934-938.
132. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489.
133. de Seze J, Lebrun C, Stojkovic T, Ferriby D, Chatel M, Vermersch P. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 2003;9:521-525.
134. Vernant JC, Cabre P, Smadja D, et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology 1997;45:58-64.
135. Fardet L, Generau T, Mikaeloff Y, Fontaine B, Seilhan D, Cabane J. Devic's neuromyelitis optica: study of nine cases. Acta Neurol Scan 2003;108:193-200.
136. Poppe AY, Lapierre Y, Melançon D, et al. Neuromyellitis optica with hypothalamic involvement. Mult Scler 2005;11:617-621.
137. Yamasaki K, Horiuchi I, Minohara M, et al. Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med 2000;39:296-299.
138. Pittock SJ, Lennon VA, Wingerchuk DM, Homburger HA, Lucchinetti CF, Weinshenker BG. The prevalence of non-organ-specific auto antibodies and NMO IgG in neuromyelitis optica (NMO) and related disorders. Neurology 2006;66:A37.
139. Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG. Neuromyelitis optica: changing concepts. J Neuroimmunol 2007;187:126-138.
140. Kister I, Gulati S, Boz C, et al. Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 2006;63:851-856.
141. Williamson PM, Neuromyelitis optica following infectious mononucleosis. Proc Aust Assoc Neurol 1975;12:153-155.
142. Doutlik S, Sblova O, Kryl R, Novak M. Neuromyelitis optica as a parainfectious complication of varicella. Cesk Neurol Neurochir 1975;38;238-242.
143. Chusid MJ, Williamson SJ, Murphy JV, Ramey LS. Neuromyelitis optica (Devic's disease) following varicella infection. J Pediatr 1979;95:737-738.
144. al-Deeb SM, Yaqub BA, Chowdhury MA, Azhar MA, Kabir F. Neuromyelitis optica (Devic's disease) following chicken pox. Trop Doct 1994;24:75-76.
145. Merle H, Smadja D, Cordoba A. Neuromyélite optique et nécrose rétinienne aigüe bilatérale d'origine zostérienne chez une patiente atteinte du SIDA. J Fr Ophtalmol 1998;21:381-386.
146. Blanche P, Diaz E, Gombert B, Sicard D. Devic's neuromyelitis optica and HIV-1 infection. J Neurol Neurosurg Psychiatry 2000;68:795-796.
147. Barbizet J, Degos JD, Meyrignac C. Devic's neuromyelitis optica and acute pulmonary tuberculosis. Rev Neurol (Paris) 1980;136:303-309.
148. Hughes RA, Mair WG. Acute necrotic myelopathy with pulmonary tuberculosis. Brain 1997;100:223-238.
149. Silber MH, Willcox PA, Bowen RM, Unger A. Neuromyelitis optica (Devic's syndrome) and pulmonary tuberculosis. Neurology1990;40:934-938.
150. Vidal Marsal F, Garcia Saavedra V, Gonzalez J, Richart Jurado C. Devic's syndrome during secondary syphilis. An Med Interna 1989;6:497-498.
151. Wilcox RA, Burrow J, Slee M, Craig J, Thyagarajan D. Neuromyelitis optica (Devic's disease) in a patient with syphilis. Mult Scler 2007. Available at www.ncbi.nlm.nih.gov/pubmed/
152. th North American Neuro-Ophthalmology Society Meeting, Rancho Mirage, California. NANOS Syllabus 2001:A32.
153. Popow NA. Neuromyelitis optica: its relation to multiple sclerosis. Dtsch Z Nervenheilk 1935;135:142-147.
154. Correale J, Fiol M. Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology 2004;63:2363-2370.
155. Ishizu T, Osoegawa M, Mei FJ, Kikuchi H, et al. Intrathecal activation of IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005;128:988-1002.
156. Nakashima I, Fujihara K, Fujimori J, Narikawa K, Misu T, Itoyama Y. Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica. Neurology 2004;62:144-146.
157. Mandler RN, Dencoff JD, Midani F, Ford CC, Ahmed W, Rosenberg GA. Matrix metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica. Brain 2001;124:493-498.
158. Filippi M, Rocca MA, Moiola L, et al. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology 1999;53:1705-1710.
159. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry. 2006;77:1073-1075.
160. Misu T, Fujihara K, Nahashima I, et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain 2002;125:2460-2468.
161. Fazekas F, Barkof F, Filippi M. Unenhanced and enhanced magnetic resonance imaging in the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64(Suppl):S2-S5.
162. Tartaglino LM, Friedman DP, Flanders AE, Lublin FD, Knobler RL, Liem M. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995;195:725-732.
163. Campi A, Filippi M, Comi G, et al. Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up.AJNR Am J Neuroradiol 1995;16:115-123.
164. Tanaka M, Tanaka K, Komori M, Saida K. Anti-aquaporin 4 antibody in Japanese multiple sclerosis: the presence of optic-spinal multiple sclerosis without long spinal cord and anti-aquaporin 4 antibody. J Neurol Neurosurg Psyhiatry 2007;78:990-992.
165. Chong HT, Ramli N, Lee KH, et al. Magnetic resonance imaging of Asians with multiple sclerosis was similar to that of the West. Can J Neurol Sci 2006;33:95-100.
166. Su JJ, Osoegawa M, Matsuoka T, et al. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci 2006;243:21-30.
167. Minohara M, Matsuoka T, Li W, et al. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J Neuroimmunol. 2006;178:156-160.
168. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007;130:1206-1223.
169. Domingues R, Kuster GW, Lanes F, Callegaro D. Recurrent neuromyelitis optica with diffuse central nervous system involvement. Arq Neuropsiquiatr 2004;62:543-546.
170. Pirko I, Blauwet LK, Lesnick TG, Weinshenker BG. The natural history of recurrent optic neuritis. Arch Neurol 2004;61:1401-1405.
171. Watanabe S, Nakashima I, Misu T, Shiga Y, Fugihara K, Itoyama Y. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007;13:128-132.
172. Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute inflammatory central nervous system inflammatory demyelinating diseases. Ann Neurol 1999;46:878-886.
173. Kleinman S, Nichols M, Strauss F, Goldfinger D. Use of lymphoplasmapheresis or plasmapheresis in the management of acute renal allograft rejection. J Clin Apheresis 1982;1:14-17.
174. Nazaki I, Hamaguchi T, Komai K, Yamada M. Fulminant Devic disease successfully treated by lymphocytapheresis. J Neurol Neurosurg Psychiatry 2006;77:1094-1102.
175. Ochi H, Wu XM, Osoegawa M, et al. Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis. J Neuroimmunol 2001;119:297-305.
176. Weinshenker BG, Wingerchuk DM, Vikusic S, et al. Neuromyelitis optica IgG predicts relapse after extensive transverse myelitis. Ann Neurol 2006;59:566-569.
177. Minagar A, Sheremata WA. Treatment of Devis'disease with methotrexate and prednisone. Int J MS Care 2000;2:39-43.
178. Bakker J, Metz L. Devic's neuromyelitis optica treated with intravenous gammaglobulin (IVIG). Can J Neurol Sci 2004;31:265-267.
179. Fidler JM, DeJoy SQ, Smith FR III, Gibbons JJ Jr. Selective immunomodulation by the antineoplastic agent mitoxantrone, II: nonspecific adherent suppressor cells derived from mitoxantrone-treated mice. J Immunol 1986;136:2747-2754.
180. Weinstock-Guttman B, Ramanathan M, Lincoff N, et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic's disease). Arch Neurol 2006;63:957-963.
181. Cree BAC, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005;64:1270-1272.
182. Capobianco M, Malucchi S, di Sapio A, et al. Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease). Neurol Sci 2207;28:209-211.
183. Wingerchuk DM. Neuromyelitis optica. Int MS J 2006;13:42-50.
184. Weinshenker BG. Western versus optic-spinal MS: two diseases, one treatment? Neurology 2005;64:594-595.
185. Warabi Y, Matsumoto Y, Hayasashi H. Interferon beta 1-b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 2007;252:57-61.
186. Gartzen K, Limmroth V, Putzki N. Relapsing neuromyelitis optica responsive to glatiramer acetate treatment. Eur J Neurol 2007;14:12-13.
187. Falcini F, Trapani S, Ricci L, Resti M, Simonini G, Martino M. Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment.Rheumatology 2006 45: 913-915.
188. Ginzler EM, Aranow C, Merrill JT, Orloff K, Henry D. Toxicity and tolerability of mycophenolate mofetil (MMF) vs intravenous cyclophosphamide (IVC) in a multicenter trial as induction therapy for lupus nephritis (LN). Arthritis Rheum 2003;48:S647.